Prognostic Biomarker after Therapy for HCC

HCC typically stems from chronically inflamed liver tissues, and the majority of patients having hepatitis B, hepatitis C, cirrhosis, high alcohol consumption, obesity, genetic disorders, or contaminated foods. After discovery of portal vein invasion in 4 HCC patients, they were excluded from logore...

Full description

Saved in:
Bibliographic Details
Published inHCPLive
Main Author Lutz, Rachel
Format Trade Publication Article
LanguageEnglish
Published Cranbury MultiMedia Healthcare Inc 09.04.2021
Subjects
Biomarkers
Hepatitis C
Liver cancer
Liver cirrhosis
Online AccessGet full text

Cover

More Information
Summary:HCC typically stems from chronically inflamed liver tissues, and the majority of patients having hepatitis B, hepatitis C, cirrhosis, high alcohol consumption, obesity, genetic disorders, or contaminated foods. After discovery of portal vein invasion in 4 HCC patients, they were excluded from logoregional therapy, but no patients in the LC group had PVT, the study authors said. sCD163 was significantly higher in cases with PVT, the study authors added, but AFP showed no difference in terms of PVT. This is aligned with previous studies, the investigators noted, but they also said they discovered a study that contradicted their association between sCD163 and vascular invasion. The study authors called age of patients, Child-Pugh score, s. albumin, and number and size of HCC focal lesions the most relevant demographic, clinical and biochemical data found in recurrent and eradicated HCC cases.
ISSN:2767-7168
2767-7168